James B. Tananbaum

Foresite Capital Management V, Llc

Assets Managed

$270.997M

Holdings

Last Quarter

2026 - Q1

Filed Date

15d ago

Growth Rate

64.84%(2Q avg: 58.02%)

Sustained Growth

3 quarters

Portfolio positions

This chart displays the top 10 holdings in Foresite Capital Management V, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 9 positions.

Assets under management

The assets under management (AUM) of Foresite Capital Management V, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 270.997M in assets, with a quarterly growth rate of 64.84% and a 2-quarter average growth rate of 58.02%. The portfolio is managed by James B. Tananbaum, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
ALMS Alumis Inc Recent Activity Increased 2.04%	47.94%	$129.911M 5.897M shares@ $22.04 avg price	Increased 2.04%
CGON Cg Oncology Inc Recent Activity	25.08%	$67.954M 1.004M shares@ $67.68 avg price
IRON Disc Medicine Inc Recent Activity Increased 25.08%	8.83%	$23.918M 374,069 shares@ $63.95 avg price	Increased 25.08%
HIMS Hims & Hers Health Inc Recent Activity Increased 170.24%	5.66%	$15.324M 738,151 shares@ $20.77 avg price	Increased 170.24%
EIKN Eikon Therapeutics Inc Recent Activity New Position	5.15%	$13.955M 1.319M shares@ $10.58 avg price	New Position
LYEL Lyell Immunopharma Inc Recent Activity	3.54%	$9.57M 477,078 shares@ $20.07 avg price
PHVS Pharvaris Nv Recent Activity New Position	2.03%	$5.484M 194,125 shares@ $28.25 avg price	New Position
NRIX Nurix Therapeutics Inc Recent Activity New Position	1.52%	$4.107M 265,000 shares@ $15.5 avg price	New Position
MAZE Maze Therapeutics Inc Recent Activity Decreased -69.97%	0.29%	$773,264 25,905 shares@ $29.85 avg price	Decreased -69.97%

1-9 of 9